Concerned about US vaccine misinformation and access, public health experts start Vaccine Integrity Project
Concerned that the nation's health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take action to curb their use, a group of public health experts is working to put pieces in place to respond.
The initiative, the Vaccine Integrity Project, will be funded by a foundation backed by Walmart heiress Christy Walton and has a steering committee helmed by former US Food and Drug Administration Commissioner Dr. Margaret Hamburg and former National Academy of Medicine President Dr. Harvey Fineberg, said Dr. Michael Osterholm, who is leading the initiative and who serves as director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
The effort will consider what's needed to safeguard vaccine policy and use in the US, including whether there's a need for a new independent body to evaluate vaccine safety and effectiveness, Osterholm said ahead of Thursday's announcement.
'There have been conversations happening for months now across the public health community about, 'what will we do if US government vaccine information becomes corrupted or the system that helps to ensure their safety and efficacy are compromised?' ' he said.
The initiative is being formed in response to actions by US Health and Human Services Secretary Robert F. Kennedy Jr., who has spread mixed messages about the measles vaccine amid a deadly outbreak, accused advisers to federal health agencies of conflicts of interest and pledged to start a major autism study that experts fear will falsely tie the condition to vaccines.
The Vaccine Integrity Project's first move will be to hold a series of information-gathering sessions, pulling together experts from local public health departments, medical associations, academia, public policy, industry and others.
The initial goal is to determine 'what is important to have going forward if, in fact, there should be compromise by the federal government in terms of our vaccine enterprise,' Osterholm said. 'We can't say at this point that that's happened, but we don't want to wait until the moment it might happen, and we have enough signals that that is.'
He pointed to Kennedy's vaccine comments, as well as moves like some Minnesota state legislators' introduction of a bill this week 'to declare that mRNA vaccine technology is a weapon of mass destruction and that it should be immediately taken off the market and anyone using it would be liable for criminal activity.'
'Who's going to respond to that?' Osterholm asked. 'Is anybody at the federal government level going to respond to activities like that? That's a question I think we are left, at this point, unanswered.'
The 'initial feedback phase,' as he called it, will start this month and last until early August.
'We don't know what's this is going to look like at the end, but we'll only find out by listening to all of these groups,' Osterholm said. 'At the end of that process, hopefully we can all look at it and come to a similar conclusion, that this is what's necessary or not necessary to protect the vaccine enterprise.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
8 ice cream flavors recalled in Ohio
WAUSEON, Ohio — An Ohio-based creamery has announced a voluntary recall due to undeclared allergens in eight of their ice cream flavors. According to the Ohio Department of Agriculture, Turkeyfoot Creek Creamery of Wauseon, Ohio, is recalling the following flavors of ice cream; Avalanche, Chocolate Peanut Butter, Chocolate Strawberry, Chocolate Brownie Bites, Cookies and Cream, Cookie Dough, Cacao and Mocha. Massive egg recall hits Ohio Walmart stores The affected products are all packaged in pint containers and were distributed to six stores, located in Canton, Cleveland, West Unity, and Arlington, Ohio. As well, as two stores located out of state, with one in Fort Wayne, Indiana, and the other in Hudson, Michigan, read a press release from the Ohio Department of Agriculture. Young mother killed in shooting at Cleveland Metroparks Mill Creek Falls 'There have been no reports of illness involving products addressed in this recall, however, individuals exhibiting signs or symptoms of an allergic reaction after consuming Turkeyfoot Creek Creamery Ice Cream involved in this recall should contact a physician immediately,' stated the release. All affected products have been removed from store shelves. Consumers can return recalled products to the place of purchase for a refund. Consumers with questions can call 419-583-7124. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
11 hours ago
- Yahoo
Massive egg recall hits Ohio Walmart stores
(WJW) – More than 1 million dozen eggs are being recalled because they could potentially be contaminated with Salmonella, according to the U.S. Food and Drug Administration. The eggs recalled by the August Egg Company of Hilmar, California, were sold under multiple different brand names at restaurants and retailers, including Walmart, according to the FDA. On Walmart's website, the company lists Ohio as an affected state for the recall. Get paid to travel the world and post about coffee: Starbucks In a statement to FOX 8, Walmart said, 'The health and safety of our customers is always a top priority. We have removed this product from impacted Walmart stores.' Here's what to check for, according to the FDA: The recalled eggs have a printed Julian Date between '32' and '126' followed by a plant code number 'P-6562' or 'CA-5330' on the egg carton or package. The recalled eggs sold at retail stores are packed in fiber or plastic cartons, with the above codes printed on one side of the carton. Brands the recalled eggs were sold under include: Clover, First Street, Nulaid, O Organics, Marketside, Raleys, Simple Truth, Sun Harvest, and Sunnyside. According to the FDA, Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Boy seen attacking baby goose at local park: police 'Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis,' warns the recall alert. Consumers who have purchased the recalled eggs are encouraged to return them to their place of purchase for a full refund. The FDA states this is an ongoing investigation and said they are working with the firm to determine if the eggs were distributed anywhere else. CLICK HERE to learn more about the recall. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
a day ago
- Yahoo
Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that's the No. 1 cause of hospitalization in infants. The US Food and Drug Administration has approved a new monoclonal antibody to help prevent infection, according to an announcement late Monday from drugmaker Merck. The therapy, Enflonsia, is designed to be given in a single 105-milligram shot to protect newborns and infants from mild, moderate or severe RSV through all five months of their first virus season, which typically starts in the fall and goes through the next spring. Study materials that Merck submitted to the FDA for its approval showed that the antibody had a similar safety profile as a placebo. The most common adverse reactions from Enflonsia were mild and included injection-site swelling and a rash in a small number of infants. In a mid- to late-stage trial, Enflonsia reduced RSV-associated hospitalizations in infants more than 84% compared with a placebo. RSV can sometimes turn into serious lower respiratory infections like pneumonia, but the shot also reduced lower respiratory infections that needed medical attention by more than 60% compared with a placebo. 'Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season,' Dr. Dean Y. Li, president of Merck Research Laboratories, said in a news release. 'We are committed to ensuring availability of Enflonsia in the US before the start of the upcoming RSV season to help reduce the significant burden of this widespread seasonal infection on families and health care systems.' Merck says it hopes Enflonsia will be available before the start of the 2025-26 respiratory virus season. First, it needs to be recommended by the US Centers for Disease Control and Prevention, and that means going in front of the agency's Advisory Committee on Immunization Practices. It's on the agenda for the panel's meeting this month, but US Health and Human Services Secretary Robert F. Kennedy removed all the members of that committee Monday. He says he will appoint new ones, but it's unclear how long that process will take. Doctors say another tool to prevent RSV cannot come soon enough. RSV is ubiquitous, one of the most common causes of childhood illness. Most kids will catch this highly contagious respiratory virus at some point before they turn 2, according to the CDC. For many healthy adults and older kids, RSV causes a mild illness like a cold. Typically, symptoms can be managed at home, and they often go away on their own. But for infants and the elderly, it can be a different story. Very young children's immune systems are just starting to learn how to fight infections, and infants have tiny airways. RSV inflames those airways, making it difficult to breathe, and can turn into a serious lower respiratory illness like bronchiolitis or pneumonia. Some of these RSV infections can be deadly. Two to three percent of infants under 6 months are hospitalized with RSV in the US every year, according to the CDC. Among children younger than 5, about 58,000 to 80,000 are hospitalized due to RSV. There's no specific medicine to treat RSV. Doctors can give an infant supportive care and oxygen, and then they essentially wait until their oxygen levels get back to normal, said Dr. Amy Edwards, director of pediatric infection control at UH Rainbow Babies and Children's Hospital in Cleveland. 'I hate RSV,' said Edwards, who was not connected with the Merck trial. 'Just to watch them struggle to breathe, and then they get scared, and then they cry, which of course makes the breathing worse, and their little lips turn blue. It's just so hard to watch.' Enflonsia joins a handful of other tools recently made available to protect babies from, although the FDA put RSV vaccine trials involving infants and young children ages 2 to 5 on hold last year after some developed severe illness. To prevent RSV in infants, the CDC currently recommends an RSV antibody made by Sanofi and AstraZeneca, called Beyfortus, which was approved in 2023. It was in short supply during that year's RSV season, although Edwards said supply started to catch up with demand in her health care system last season, and the company pledged to produce more. The other option to protect an infant is a vaccine that a person can get during pregnancy. Together, Beyfortus and the vaccine have made a difference. A CDC study published in March found that RSV-associated hospitalization rates among infants up to 7 months during 2024-25 season were lower than in seasons when those therapies weren't available. Edwards just hopes people will get protection for their infants. 'Every RSV season fills us to the gills,' she said. 'This should theoretically empty us out, if we have good uptake.'
